Fort Worth biotech company Eyevance Pharmaceuticals acquired in $225M deal

A Fort Worth-based biotech company focused on ophthalmic products has been acquired by the U.S. subsidiary of a Japanese pharmaceutical firm.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.